# US 2019/0376112 A1 · Method of evaluating neutrophil activity

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2019/0376112 A1
- Document ID: US20190376112A1
- Status: Published application
- Kind: A1
- Application number: 16/435,710
- Filed: 2019-06-10
- Published: 2019-12-12
- Earliest claimed: 2018-06-11
- Assignees: Hamamatsu Photonics K.K.
- Applicants: Hamamatsu Photonics K.K.
- Inventors: Kimiko KAZUMURA; Kozo TAKEUCHI
- Web page: https://patentgrep.com/patent/US20190376112A1

## CPC

- C12Q 1/28: involving peroxidase
- G01N 21/76: Chemiluminescence; Bioluminescence
- G01N 33/5094: {for blood cell populations (red blood cells G01N33/80)}
- G01N 2800/7009: Oxidative stress
- C12Q: MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)

## Abstract

The present invention relates to a method of evaluating neutrophil activity, which includes: evaluating neutrophil activity based on an index derived from measurement results of myeloperoxidase (MPO) activity or superoxide production of a biological sample to which a neutrophil stimulant is added, in which the index is a time from addition of the neutrophil stimulant to rise of a peak of the MPO activity or the superoxide production.

## Claims

### Claim 1

A method of evaluating neutrophil activity, comprising:
evaluating neutrophil activity based on an index derived from measurement results of myeloperoxidase (MPO) activity or superoxide production of a biological sample to which a neutrophil stimulant is added,
wherein the index is a time from addition of the neutrophil stimulant to rise of a peak of the MPO activity or the superoxide production.

### Claim 2 (depends on 1)

The method according to claim 1,
wherein the evaluating includes comparing the time to a reference value and determining that neutrophil sensitivity is reduced in a case where the time is greater than the reference value.

### Claim 3 (depends on 1)

The method according to claim 1,
wherein the biological sample is a sample containing whole blood.

### Claim 4 (depends on 2)

The method according to claim 2,
wherein the biological sample is a sample containing whole blood.

### Claim 5 (depends on 1)

The method according to claim 1,
wherein the evaluating further includes evaluating the neutrophil activity based on a peak area of the MPO activity or the superoxide production.

### Claim 6 (depends on 2)

The method according to claim 2,
wherein the evaluating further includes evaluating the neutrophil activity based on a peak area of the MPO activity or the superoxide production.

### Claim 7 (depends on 3)

The method according to claim 3,
wherein the evaluating further includes evaluating the neutrophil activity based on a peak area of the MPO activity or the superoxide production.

### Claim 8 (depends on 4)

The method according to claim 4,
wherein the evaluating further includes evaluating the neutrophil activity based on a peak area of the MPO activity or the superoxide production.

### Claim 9

A method of collecting data for determining whether or not a subject is suffering from a disease associated with oxidative stress due to excessively activated neutrophils, or whether or not the subject is in a condition associated with oxidative stress due to excessively activated neutrophils, the method comprising:
deriving the data from measurement results of MPO activity or superoxide production of a biological sample to which a neutrophil stimulant is added,
wherein the data is a time from addition of the neutrophil stimulant to rise of a peak of the MPO activity or the superoxide production, and
the biological sample is a biological sample collected from the subject.

### Claim 10

A method of collecting data for determining effect of treatment on a disease or a condition associated with oxidative stress due to excessively activated neutrophils, in a subject, the method comprising:
deriving the data from measurement results of MPO activity or superoxide production of a biological sample to which a neutrophil stimulant is added,
wherein the data is a time from addition of the neutrophil stimulant to rise of a peak of the MPO activity or the superoxide production, and
the biological sample is a biological sample collected from the subject after the treatment.
